Societal CDMO, Inc. (SCTL) Research

Societal CDMO, Inc., an organization founded in Exton, Pennsylvania, in 2007, functions as a contract development and manufacturing partner for the global pharmaceutical industry. Formerly known as Recro Pharma, Inc. until its name change in March 2022, the company specializes in supporting small molecule therapeutic advancements. Its comprehensive services span the entire drug development lifecycle, from initial research and development to manufacturing and packaging various therapeutic dosage forms for both domestic and international markets. Key offerings include drug development expertise, end-to-end regulatory guidance, clinical and commercial scale production, sterile fill/finish operations, freeze-drying (lyophilization), and integrated packaging and logistics solutions.

Market snapshot

Symbol
SCTL
Price
$1.10
Day change
+0.92%
Market cap
$116.1M
P/E ratio
-7.89x
52-week range
0.26-1.28
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Augmedix, Inc. (AUGX)
  • Cyteir Therapeutics, Inc. (CYT)
  • Decibel Therapeutics, Inc. (DBTX)
  • Graybug Vision, Inc. (GRAY)
  • Opiant Pharmaceuticals, Inc. (OPNT)
  • OptiNose, Inc. (OPTN)
  • Procaps Group S.A. (PROC)
  • Sesen Bio, Inc. (SESN)

Recent insider activity

  • Arens Mathew Paul — U-Tender (19676396 shares) on 2024-04-08
  • Arens Mathew Paul — D-Return (20000 shares) on 2024-04-08
  • Arens Mathew Paul — D-Return (1250000 shares) on 2024-04-08
  • Weisman Wayne — U-Tender (234982 shares) on 2024-04-08
  • Weisman Wayne — D-Return (118182 shares) on 2024-04-08

Open Societal CDMO, Inc. (SCTL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.